209 related articles for article (PubMed ID: 18606839)
21. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.
Holmes RL; Jorgensen JH
Antimicrob Agents Chemother; 2008 Feb; 52(2):757-60. PubMed ID: 18039923
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model.
Xiong YQ; Fowler VG; Yeaman MR; Perdreau-Remington F; Kreiswirth BN; Bayer AS
J Infect Dis; 2009 Jan; 199(2):201-8. PubMed ID: 19086913
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.
Gould IM
J Infect Dis; 2012 Mar; 205(5):864-5; author reply 865-6. PubMed ID: 22238463
[No Abstract] [Full Text] [Related]
26. Antimicrobial salvage therapy for native valve MRSA endocarditis.
Cortes J; Sagar AS; Lee Y; Sandhu U; Boka K
J Antimicrob Chemother; 2017 Jun; 72(6):1841-1842. PubMed ID: 28333236
[No Abstract] [Full Text] [Related]
27. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD
Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
[TBL] [Abstract][Full Text] [Related]
28. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy.
Sieradzki K; Leski T; Dick J; Borio L; Tomasz A
J Clin Microbiol; 2003 Apr; 41(4):1687-93. PubMed ID: 12682161
[TBL] [Abstract][Full Text] [Related]
29. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
[TBL] [Abstract][Full Text] [Related]
30. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
[TBL] [Abstract][Full Text] [Related]
31. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
32. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
[TBL] [Abstract][Full Text] [Related]
33. Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).
Cunha BA; Pherez FM
Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):831-3. PubMed ID: 19184141
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of mitral MRSA endocarditis using daptomycin].
Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
[No Abstract] [Full Text] [Related]
35. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Sakoulas G; Moellering RC; Eliopoulos GM
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
[TBL] [Abstract][Full Text] [Related]
36. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.
Lodise TP; Graves J; Evans A; Graffunder E; Helmecke M; Lomaestro BM; Stellrecht K
Antimicrob Agents Chemother; 2008 Sep; 52(9):3315-20. PubMed ID: 18591266
[TBL] [Abstract][Full Text] [Related]
37. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Holubar M; Meng L; Deresinski S
Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
[TBL] [Abstract][Full Text] [Related]
38. A report on the first case of vancomycin-intermediate Staphylococcus aureus (VISA) in Hawai'i.
Chaiwongkarjohn S; Pramyothin P; Suwantarat N; Bankowski MJ; Koyamatsu T; Seifried SE; Bello EF
Hawaii Med J; 2011 Nov; 70(11):233-6. PubMed ID: 22162601
[TBL] [Abstract][Full Text] [Related]
39. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ
Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539
[TBL] [Abstract][Full Text] [Related]
40. Management of methicillin-resistant Staphylococcus aureus bacteremia.
Cosgrove SE; Fowler VG
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S386-93. PubMed ID: 18462094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]